Evidence map›Paper›PMID 38004702›Full record

ArticleMicroorganisms2023

Distinct Effects of Moxifloxacin and Bedaquiline on Growing and 'Non-Culturable'

Andrey L Mulyukin, Deborah Recchia, Nadezhda A Kostrikina, Maria V Artyukhina, Billy A Martini, Alessandro Stamilla, Giulia Degiacomi, Elena G Salina

Open access · goldAbstract read
In one paragraph

Article in Microorganisms, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Insights intoFrontiers in cellular and infection microbiology · 2025
    Article
  5. Fate ofFrontiers in microbiology · 2024
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Andrey L MulyukinWinogradsky Institute of Microbiology, Research Center of Biotechnology of the Russian Academy of Sciences, 119071 Moscow, Russia.ORCID 0000-0002-3524-1328
Deborah RecchiaDepartment of Biology and Biotechnology "Lazzaro Spallanzani", University of Pavia, 27100 Pavia, Italy.
Nadezhda A KostrikinaWinogradsky Institute of Microbiology, Research Center of Biotechnology of the Russian Academy of Sciences, 119071 Moscow, Russia.
Maria V ArtyukhinaBach Institute of Biochemistry, Research Center of Biotechnology of the Russian Academy of Sciences, 119071 Moscow, Russia.
Billy A MartiniBach Institute of Biochemistry, Research Center of Biotechnology of the Russian Academy of Sciences, 119071 Moscow, Russia.
Alessandro StamillaDepartment of Biology and Biotechnology "Lazzaro Spallanzani", University of Pavia, 27100 Pavia, Italy.ORCID 0000-0001-7065-1501
Giulia DegiacomiDepartment of Biology and Biotechnology "Lazzaro Spallanzani", University of Pavia, 27100 Pavia, Italy.ORCID 0000-0002-3626-8311
Elena G SalinaBach Institute of Biochemistry, Research Center of Biotechnology of the Russian Academy of Sciences, 119071 Moscow, Russia.ORCID 0000-0001-9616-6598
A N Bach Institute of Biochemistry · RUUniversity of Pavia · ITRussian Academy of Sciences · RU

Funding

EU PE00000007Italian Cystic Fibrosis Foundation FFC#18/2021Russian Ministry of Science and Higher EducationRussian Science Foundation 23-15-00173
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

bactericidal activitydrug toleranceMycobacterium abscessusnon-culturabilityviability

Identifiers

PMID38004702
PMCPMC10673116
OpenAlexW4388275470

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.